Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
LEAC-102 / Taiwan Bio
NCT02826837: LEAC-102 for Advanced Colorectal Cancer	Not yet recruiting	1/2	30	NA	LEAC-102 500mg capsule and FOLFOX + Bevacizumab/Cetuximab	Taiwan Leader Biotech Corp.	Advanced Colorectal Cancer	02/24	02/24